Who owns CNS Pharmaceuticals Inc?
- Ticker: CNSP
- CUSIP Number: 18978h508
Tip: Access positions for across all investors
Analyze quarterly positions in CNS Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of CNS Pharmaceuticals stock
Who bought or sold CNS Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Stonepine Capital Management | 49k | $256k | 100% | Dec 2025 |
|
| Ikarian Capital | 46k | $110k | 0% | Mar 2026 |
|
| Geode Capital Management | 23k | $56k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 14k | $32k | 0% | Mar 2026 |
|
| UBS Group | 729.00 | $1.7k | 19% | Mar 2026 |
|
| Barrett & Company | 8.00 | $19.000000 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 3.00 | $8.000100 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $2.000000 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $2.000000 | 0% | Mar 2026 |
|
Who sold out of CNS Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 15k | $81k |